Geninus (XKRX:389030) ROCE % : -32.35% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Geninus ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Geninus's annualized ROCE % for the quarter that ended in Mar. 2024 was -32.35%.

Geninus ROCE % Historical Data

The historical data trend for Geninus's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Geninus ROCE % Chart

Geninus Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

-155.20

-35.44

-19.53

-24.35

Geninus Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial									-22.14	-14.58	-27.78	-35.74	-32.35

Geninus ROCE % Calculation

Geninus's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-9637.154	/	( ( (45829.771 - 2306.162)	+	(40526.26 - 4895.225) )	/ 2 )
	=	-9637.154	/	( (43523.609	+	35631.035)	/ 2 )
	=	-9637.154	/	39577.322
	=	-24.35 %

Geninus's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	-11076.216	/	( ( (40526.26 - 4895.225)	+	(40889.549 - 8043.595) )	/ 2 )
	=	-11076.216	/	( ( 35631.035	+	32845.954 )	/ 2 )
	=	-11076.216	/	34238.4945
	=	-32.35 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Geninus (XKRX:389030) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Geninus ROCE % Related Terms

Thank you for viewing the detailed overview of Geninus's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Geninus (XKRX:389030) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Geninus Inc (XKRX:389030) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

70, Jeongui-ro, 4th and 5th Floors, Songpa-gu, Munjeong-dong, KD U Tower, Seoul, KOR, 05836

Website

http://www.kr-geninus.com

Geninus Inc provides clinical genome analysis solutions for precision medicine clinics.

Geninus (XKRX:389030) Headlines

No Headlines